RecallRadar
High RiskReported March 11, 2026

SILINTAN 25/pills, packaged in a 25-count bottle

Recalled by ANTHONY TRINH, 123Herbals LLC

Drug recall

ANTHONY TRINH, 123Herbals LLC

Class I — most serious

There is a reasonable chance that using this product could cause serious health problems or death.

See all recalls involving an undeclared allergen

ANTHONY TRINH, 123Herbals LLC has recalled SILINTAN 25/pills, packaged in a 25-count bottle, according to data published by the U.S. Food and Drug Administration (FDA). The recall was reported on March 11, 2026 and was initiated on October 20, 2025. It is classified as a Class I recall, which means there is a reasonable chance that using this product could cause serious health problems or death.

Below is a plain-English summary of what was recalled, why it was recalled, how to tell whether you have the affected product, and what steps you can take. For the complete and most current details, you can view the FDA record linked further down this page.

What was recalled?

This recall covers SILINTAN 25/pills, packaged in a 25-count bottle, with approximately N/A affected. The company behind the recall is ANTHONY TRINH, 123Herbals LLC, based in Rosemead, CA. The FDA describes the product as: “SILINTAN 25/pills, packaged in a 25-count bottle, Shanghai Chinese Medical Works, Shanghai, China”

Why was SILINTAN 25/pills, packaged in a 25-count bottle recalled?

According to the FDA, the stated reason for the recall is: “Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared meloxicam.” In plain terms, this recall relates to an undeclared ingredient or allergen.

An undeclared ingredient means a food contains something — often a major allergen such as milk, eggs, soy, wheat, peanuts, or tree nuts — that is not listed on the label. For most people this is not dangerous, but for someone with a food allergy or sensitivity it can trigger a serious reaction. Accurate labeling is required so that people can avoid ingredients they need to stay away from.

What should you do?

If you think you may have bought SILINTAN 25/pills, packaged in a 25-count bottle, compare it against the product description and identifying codes (All lots within expiry) before using it. This recall is currently listed as ongoing.

The general guidance for a matching product is to stop using it and follow the instructions in the official FDA recall notice, which may include a repair, replacement, refund, or safe disposal. When in doubt, contact ANTHONY TRINH, 123Herbals LLC or your local health authority.

About this recall

This recall was distributed in CA. RecallRadar summarizes recall information from public FDA data to make it easier to understand. We are an independent service and are not affiliated with the FDA or any government agency, so please always refer to the official source for the authoritative record — and note the “last synced” date shown on this page, since recall details can change over time.

Full recall details

Status
Ongoing
Date reported
March 11, 2026
Recall started
October 20, 2025
Distributed in
CA
What was recalled
SILINTAN 25/pills, packaged in a 25-count bottle, Shanghai Chinese Medical Works, Shanghai, China
Why it was recalled (as stated by the FDA)
Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared meloxicam.
How to identify the affected product
All lots within expiry
Amount recalled
N/A

What you can do

Check whether any product you have matches the description and codes above. If it does, stop using it and follow the instructions in the official recall notice. When in doubt, contact the company or your local health authority.

Quick answers

Why was SILINTAN 25/pills, packaged in a 25-count bottle recalled?+

According to the FDA: Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared meloxicam.

How serious is this recall?+

Class I — most serious. There is a reasonable chance that using this product could cause serious health problems or death.

What should I do if I have SILINTAN 25/pills, packaged in a 25-count bottle?+

Compare your product against the description and identifying codes on this page. If it matches, stop using it and follow the instructions in the official recall notice — this usually means returning it for a refund or discarding it. When in doubt, contact the company or your local health authority.

Share this recall:PostShareEmail
View the official FDA record

Opens the U.S. Food and Drug Administration (FDA) data for this recall.

Recall number: D-0388-2026. Information last synced from the FDA on July 5, 2026.